Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Strong margins and returns
About
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Target Price
The average target price of MCAP.ST is 563 and suggests 9% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell